Disposition of 2025 shares by Khan Nasser of Acadia Healthcare at 72.51 subject to Rule 16b-3
| RUDAX Fund | USD 22.67 0.00 0.00% |
Slightly above 55% of Dreyfus/the Boston's investor base is interested to short. The analysis of overall sentiment of trading Dreyfusthe Boston Pany mutual fund suggests that many investors are impartial at this time. Dreyfus/the Boston's investing sentiment can be driven by a variety of factors including economic data, Dreyfus/the Boston's earnings reports, geopolitical events, and overall market trends.
Dreyfus/the |
Filed transaction by Acadia Healthcare Officer: Chief Operating Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at accesswire.com
 |
Dreyfus/the Boston Fundamental Analysis
We analyze Dreyfus/the Boston's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus/the Boston using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus/the Boston based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Dreyfusthe Boston is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Dreyfusthe Boston Pany Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus/the Boston mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus/the Boston could also be used in its relative valuation, which is a method of valuing Dreyfus/the Boston by comparing valuation metrics with similar companies.
Peers
Dreyfus/the Boston Related Equities
| BHCHX | Baron Health | 0.19 | ||||
| SBHIX | Health Biotchnology | 0.00 | ||||
| BGHDX | Baillie Gifford | 0.00 | ||||
| FHCCX | Fidelity Advisor | 0.14 | ||||
| LOGSX | Live Oak | 0.23 | ||||
| THQ | Tekla Healthcare | 0.67 | ||||
| ETCHX | Eventide Healthcare | 0.80 |
Other Information on Investing in Dreyfus/the Mutual Fund
Dreyfus/the Boston financial ratios help investors to determine whether Dreyfus/the Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus/the with respect to the benefits of owning Dreyfus/the Boston security.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |